Kymera Therapeutics, Inc. (KYMR)

74.85 +0.72 (+0.97%) USD  |  NASDAQ  |  Jan 14, 12:00
More

Kymera Therapeutics Change in Receivables (TTM)

Change in Receivables (TTM) Chart

View Change in Receivables (TTM) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (TTM) Range, Past 5 Years

View Change in Receivables (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (TTM) Benchmarks

View Change in Receivables (TTM) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Cytokinetics, Inc. Upgrade
TG Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade